Capstone Therapeutics Corp. Business Operations Contracts & Agreements

19 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
LipimetiX Development, Inc. Contingent Value Rights Agreement, dated August 23, 2019, by and among Capstone Therapeutics Corp., the Shareholder Representative and Computershare...
Development Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2024
Amendment of Amended and Restated Management Fee and Transaction Fee Agreement, dated November 15, 2024, by and between Capstone Holding Corp., TotalStone, LLC, and Brookstone...
Management Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2024
Management Fee Agreement, dated March 27, 2020, by and between TotalStone, LLC and Capstone Holding Corp
Management Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2024
Brookstone Partners IAC, Inc. Amended and Restated Management Fee Agreement Dated March 1, 2020 by and between TotalStone, LLC and Brookstone Partners IAC, Inc
Management Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2024
Consent and First Amendment to the Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March 27, 2020 and Effective as of November 26, 2021
Operating Agreements
Capstone Therapeutics Corp.
Biotechnology
2024
Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March 27, 2020 and Effective as of November 26, 2021
Operating Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2024
FIRST AMENDMENT TO BYLAWS OF LIPIMETIX DEVELOPMENT, INC. (August 10, 2017)
Development Agreements
Capstone Therapeutics Corp.
Biotechnology
2017
CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIPIMETIX DEVELOPMENT, INC.
Development Agreements
Capstone Therapeutics Corp.
Biotechnology
2017
FIRST AMENDMENT TO THE AMENDED AND RESTATEDSTOCKHOLDERS AGREEMENT OF LIPIMETIX DEVELOPMENT, INC.
Development Agreements
Capstone Therapeutics Corp.
Biotechnology
2017
AMENDED AND RESTATED STOCKHOLDERS AGREEMENT among LIPIMETIX DEVELOPMENT, INC. and THE STOCKHOLDERS NAMED HEREIN Dated as of August 25, 2016
Development Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2016
ACCOUNTING SERVICES Agreement
Services Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2016
Management Agreement
Management Agreements
Capstone Therapeutics Corp.
Biotechnology
MA
2016
STOCKHOLDERS AGREEMENT among LIPIMETIX DEVELOPMENT, INC. and THE STOCKHOLDERS NAMED HEREIN Dated as of June 23, 2015 LIPIMETIX DEVELOPMENT, INC. STOCKHOLDERS AGREEMENT
Development Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2015
ACCOUNTING SERVICES AGREEMENT AMENDMENT #1
Services Agreements
Capstone Therapeutics Corp.
Biotechnology
2013
EXHIBIT 10.5EXECUTION ACCOUNTING SERVICES AGREEMENT
Services Agreements
Capstone Therapeutics Corp.
Biotechnology
AZ
2012
MANAGEMENT AGREEMENT
Management Agreements
Capstone Therapeutics Corp.
Biotechnology
WA
2012
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF LIPIMETIX DEVELOPMENT, LLC
Development Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2012
Amendment No. 3, dated November 4, 2008, to the Management Services Agreement effective May 12, 2006 by and between AGP Management, LP, John M. Holliman, III, Executive Chairman,...
Management Agreements
Capstone Therapeutics Corp.
Biotechnology
2008
INDEMNIFICATION AGREEMENT
Indemnification Agreements
Capstone Therapeutics Corp.
Biotechnology
DE
2006